

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.97910475 |
| 2 | L-phenylalanine metabolic process (GO:0006558) | 6.97910475 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.97698917 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 6.97698917 |
| 5 | sulfur amino acid catabolic process (GO:0000098) | 6.24556806 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.18056526 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.79300589 |
| 8 | proline biosynthetic process (GO:0006561) | 5.73892640 |
| 9 | glyoxylate metabolic process (GO:0046487) | 5.67483649 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 5.45960122 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.45960122 |
| 12 | tryptophan catabolic process (GO:0006569) | 5.45960122 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.43329347 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.36244556 |
| 15 | proline metabolic process (GO:0006560) | 5.25723088 |
| 16 | virion attachment to host cell (GO:0019062) | 5.23303590 |
| 17 | adhesion of symbiont to host cell (GO:0044650) | 5.23303590 |
| 18 | cysteine metabolic process (GO:0006534) | 5.17989014 |
| 19 | angiotensin maturation (GO:0002003) | 5.13614532 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.12878975 |
| 21 | tryptophan metabolic process (GO:0006568) | 5.10673735 |
| 22 | urea metabolic process (GO:0019627) | 5.08937991 |
| 23 | urea cycle (GO:0000050) | 5.08937991 |
| 24 | negative regulation of fibrinolysis (GO:0051918) | 5.02234413 |
| 25 | serine family amino acid catabolic process (GO:0009071) | 5.00446111 |
| 26 | high-density lipoprotein particle remodeling (GO:0034375) | 4.95511520 |
| 27 | bile acid metabolic process (GO:0008206) | 4.89230199 |
| 28 | triglyceride homeostasis (GO:0070328) | 4.87679091 |
| 29 | acylglycerol homeostasis (GO:0055090) | 4.87679091 |
| 30 | protein carboxylation (GO:0018214) | 4.83437804 |
| 31 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.83437804 |
| 32 | complement activation, alternative pathway (GO:0006957) | 4.81204933 |
| 33 | regulation of fibrinolysis (GO:0051917) | 4.78336397 |
| 34 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 4.78007494 |
| 35 | nitrogen cycle metabolic process (GO:0071941) | 4.76250606 |
| 36 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.75740918 |
| 37 | regulation of protein activation cascade (GO:2000257) | 4.72614633 |
| 38 | glutamine family amino acid biosynthetic process (GO:0009084) | 4.62528364 |
| 39 | adhesion of symbiont to host (GO:0044406) | 4.61842789 |
| 40 | aromatic amino acid family metabolic process (GO:0009072) | 4.52912921 |
| 41 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.46203212 |
| 42 | regulation of complement activation (GO:0030449) | 4.42178996 |
| 43 | alpha-amino acid catabolic process (GO:1901606) | 4.34856318 |
| 44 | regulation of triglyceride catabolic process (GO:0010896) | 4.34488048 |
| 45 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.34120871 |
| 46 | cholesterol efflux (GO:0033344) | 4.33400192 |
| 47 | heme transport (GO:0015886) | 4.32523936 |
| 48 | regulation of cholesterol esterification (GO:0010872) | 4.32096472 |
| 49 | lysine metabolic process (GO:0006553) | 4.27705804 |
| 50 | lysine catabolic process (GO:0006554) | 4.27705804 |
| 51 | reverse cholesterol transport (GO:0043691) | 4.27341058 |
| 52 | plasma lipoprotein particle assembly (GO:0034377) | 4.25429286 |
| 53 | homocysteine metabolic process (GO:0050667) | 4.24400306 |
| 54 | tyrosine metabolic process (GO:0006570) | 4.23142706 |
| 55 | protein-lipid complex remodeling (GO:0034368) | 4.21042682 |
| 56 | macromolecular complex remodeling (GO:0034367) | 4.21042682 |
| 57 | plasma lipoprotein particle remodeling (GO:0034369) | 4.21042682 |
| 58 | plasma lipoprotein particle clearance (GO:0034381) | 4.18191043 |
| 59 | glycine metabolic process (GO:0006544) | 4.16908831 |
| 60 | cytolysis (GO:0019835) | 4.15551835 |
| 61 | cellular amino acid catabolic process (GO:0009063) | 4.11508894 |
| 62 | amino-acid betaine metabolic process (GO:0006577) | 4.11479898 |
| 63 | alkaloid metabolic process (GO:0009820) | 4.08149191 |
| 64 | serine family amino acid metabolic process (GO:0009069) | 4.06258324 |
| 65 | negative regulation of sterol transport (GO:0032372) | 4.05646779 |
| 66 | negative regulation of cholesterol transport (GO:0032375) | 4.05646779 |
| 67 | acetyl-CoA metabolic process (GO:0006084) | 4.03138261 |
| 68 | phospholipid efflux (GO:0033700) | 3.99441986 |
| 69 | NADH metabolic process (GO:0006734) | 3.99201690 |
| 70 | regulation of cholesterol homeostasis (GO:2000188) | 3.97436730 |
| 71 | imidazole-containing compound metabolic process (GO:0052803) | 3.94855121 |
| 72 | glycosphingolipid catabolic process (GO:0046479) | 3.87805281 |
| 73 | glutamate metabolic process (GO:0006536) | 3.83460828 |
| 74 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.82284524 |
| 75 | protein-lipid complex assembly (GO:0065005) | 3.81933879 |
| 76 | coenzyme catabolic process (GO:0009109) | 3.81877668 |
| 77 | ethanol oxidation (GO:0006069) | 3.80956320 |
| 78 | cellular ketone body metabolic process (GO:0046950) | 3.80531715 |
| 79 | epoxygenase P450 pathway (GO:0019373) | 3.80023668 |
| 80 | cellular biogenic amine catabolic process (GO:0042402) | 3.78396401 |
| 81 | amine catabolic process (GO:0009310) | 3.78396401 |
| 82 | indolalkylamine metabolic process (GO:0006586) | 3.75618865 |
| 83 | bile acid and bile salt transport (GO:0015721) | 3.75168923 |
| 84 | intestinal cholesterol absorption (GO:0030299) | 3.72208164 |
| 85 | serine family amino acid biosynthetic process (GO:0009070) | 3.71019415 |
| 86 | cholesterol homeostasis (GO:0042632) | 3.70664465 |
| 87 | transcription from mitochondrial promoter (GO:0006390) | 3.70031927 |
| 88 | barbed-end actin filament capping (GO:0051016) | 3.68712939 |
| 89 | glycolipid catabolic process (GO:0019377) | 3.68569483 |
| 90 | cellular glucuronidation (GO:0052695) | 3.64574162 |
| 91 | sterol homeostasis (GO:0055092) | 3.64093651 |
| 92 | arginine metabolic process (GO:0006525) | 3.64000611 |
| 93 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.62464795 |
| 94 | organic acid catabolic process (GO:0016054) | 3.61329313 |
| 95 | carboxylic acid catabolic process (GO:0046395) | 3.61329313 |
| 96 | cellular modified amino acid catabolic process (GO:0042219) | 3.61100356 |
| 97 | NAD biosynthetic process (GO:0009435) | 3.58723682 |
| 98 | aldehyde catabolic process (GO:0046185) | 3.57484342 |
| 99 | benzene-containing compound metabolic process (GO:0042537) | 3.57475692 |
| 100 | plasma lipoprotein particle organization (GO:0071827) | 3.56602196 |
| 101 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.56357392 |
| 102 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.56357392 |
| 103 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.54295778 |
| 104 | cyclooxygenase pathway (GO:0019371) | 3.53355165 |
| 105 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.52604364 |
| 106 | drug catabolic process (GO:0042737) | 3.51570364 |
| 107 | fibrinolysis (GO:0042730) | 3.51230390 |
| 108 | cofactor catabolic process (GO:0051187) | 3.49537205 |
| 109 | fatty acid beta-oxidation (GO:0006635) | 3.49048743 |
| 110 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.48158666 |
| 111 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.48158666 |
| 112 | positive regulation of lipid catabolic process (GO:0050996) | 3.46599987 |
| 113 | renal system process involved in regulation of blood volume (GO:0001977) | 3.41237358 |
| 114 | low-density lipoprotein particle remodeling (GO:0034374) | 3.40263735 |
| 115 | protein retention in ER lumen (GO:0006621) | 3.37583340 |
| 116 | L-ascorbic acid metabolic process (GO:0019852) | 3.35782239 |
| 117 | fructose metabolic process (GO:0006000) | 3.27316951 |
| 118 | ceramide catabolic process (GO:0046514) | 3.11321148 |
| 119 | regulation of mononuclear cell migration (GO:0071675) | 3.08385195 |
| 120 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.05047668 |
| 121 | peptide catabolic process (GO:0043171) | 2.99711076 |
| 122 | glycoside metabolic process (GO:0016137) | 2.99304076 |
| 123 | xenobiotic catabolic process (GO:0042178) | 2.97488911 |
| 124 | heme metabolic process (GO:0042168) | 2.96394791 |
| 125 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.91926837 |
| 126 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.85836282 |
| 127 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.82247270 |
| 128 | oligosaccharide catabolic process (GO:0009313) | 2.81652151 |
| 129 | hydrogen peroxide catabolic process (GO:0042744) | 2.80952138 |
| 130 | regulation of early endosome to late endosome transport (GO:2000641) | 2.75243328 |
| 131 | glutathione metabolic process (GO:0006749) | 2.75045339 |
| 132 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.73944553 |
| 133 | membrane lipid catabolic process (GO:0046466) | 2.71695933 |
| 134 | heme biosynthetic process (GO:0006783) | 2.71411452 |
| 135 | sphingolipid catabolic process (GO:0030149) | 2.69974320 |
| 136 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.69115546 |
| 137 | hemoglobin metabolic process (GO:0020027) | 2.67700476 |
| 138 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.67492673 |
| 139 | cellular response to arsenic-containing substance (GO:0071243) | 2.65687479 |
| 140 | hormone catabolic process (GO:0042447) | 2.65538882 |
| 141 | regulation of vitamin metabolic process (GO:0030656) | 2.64954569 |
| 142 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.64816897 |
| 143 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.64149916 |
| 144 | response to nitrosative stress (GO:0051409) | 2.63359568 |
| 145 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.62755662 |
| 146 | drug metabolic process (GO:0017144) | 2.62529100 |
| 147 | arachidonic acid metabolic process (GO:0019369) | 2.61720003 |
| 148 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.57219129 |
| 149 | tooth mineralization (GO:0034505) | 2.56359645 |
| 150 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.53213409 |
| 151 | glutathione derivative metabolic process (GO:1901685) | 2.53155433 |
| 152 | glutathione derivative biosynthetic process (GO:1901687) | 2.53155433 |
| 153 | lipoprotein transport (GO:0042953) | 2.52092241 |
| 154 | porphyrin-containing compound metabolic process (GO:0006778) | 2.49140142 |
| 155 | fibril organization (GO:0097435) | 2.48316467 |
| 156 | extracellular fibril organization (GO:0043206) | 2.46812456 |
| 157 | pinocytosis (GO:0006907) | 2.46644709 |
| 158 | hyaluronan catabolic process (GO:0030214) | 2.46375215 |
| 159 | protein neddylation (GO:0045116) | 2.46060655 |
| 160 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.45835755 |
| 161 | glutathione biosynthetic process (GO:0006750) | 2.45477799 |
| 162 | intestinal absorption (GO:0050892) | 2.43830464 |
| 163 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.40534546 |
| 164 | fat-soluble vitamin metabolic process (GO:0006775) | 2.40289518 |
| 165 | protein maturation by protein folding (GO:0022417) | 2.38430511 |
| 166 | omega-hydroxylase P450 pathway (GO:0097267) | 2.38197624 |
| 167 | regulation of cholesterol storage (GO:0010885) | 2.36237771 |
| 168 | regulation of response to osmotic stress (GO:0047484) | 2.34195818 |
| 169 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.33654830 |
| 170 | regulation of monocyte chemotaxis (GO:0090025) | 2.32823465 |
| 171 | vitamin biosynthetic process (GO:0009110) | 2.31996054 |
| 172 | low-density lipoprotein particle clearance (GO:0034383) | 2.31972838 |
| 173 | amyloid precursor protein catabolic process (GO:0042987) | 2.31809034 |
| 174 | regulation of guanylate cyclase activity (GO:0031282) | 2.31571563 |
| 175 | cellular response to cadmium ion (GO:0071276) | 2.31143464 |
| 176 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.30892052 |
| 177 | ethanol metabolic process (GO:0006067) | 2.30851553 |
| 178 | response to thyroid hormone (GO:0097066) | 2.29567009 |
| 179 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.29522851 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.56810052 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.35304277 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.22810054 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.54800035 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.23042109 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.80507013 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.64557735 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.37645805 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.60782909 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.59613967 |
| 11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.94940064 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05589556 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.03788111 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.98836738 |
| 15 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.82755728 |
| 16 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.76280936 |
| 17 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.72446352 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.71485144 |
| 19 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.70089496 |
| 20 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.66957400 |
| 21 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.65786825 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.65407906 |
| 23 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.60316912 |
| 24 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.58056855 |
| 25 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.57266370 |
| 26 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.55913168 |
| 27 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.48954820 |
| 28 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.41643062 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.40332537 |
| 30 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.39412666 |
| 31 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.39412666 |
| 32 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.39412666 |
| 33 | P68_20966046_ChIP-Seq_HELA_Human | 1.38702077 |
| 34 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.38661271 |
| 35 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.37929512 |
| 36 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.37682638 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.34484441 |
| 38 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.31867036 |
| 39 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.31074663 |
| 40 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.30639647 |
| 41 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.29480616 |
| 42 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.29401642 |
| 43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.29014724 |
| 44 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.28002573 |
| 45 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.27310337 |
| 46 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.23931435 |
| 47 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.23349948 |
| 48 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.23102833 |
| 49 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.22718329 |
| 50 | SA1_27219007_Chip-Seq_Bcells_Human | 1.20402263 |
| 51 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.20007114 |
| 52 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.20005073 |
| 53 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19773922 |
| 54 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.19371233 |
| 55 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.18654970 |
| 56 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.17243110 |
| 57 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.16961334 |
| 58 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16455750 |
| 59 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15923416 |
| 60 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15348826 |
| 61 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.15097328 |
| 62 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.13722417 |
| 63 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12290246 |
| 64 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.10870099 |
| 65 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.10460161 |
| 66 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.10111749 |
| 67 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09738624 |
| 68 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08771899 |
| 69 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.08454364 |
| 70 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.07471277 |
| 71 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.07447086 |
| 72 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07417292 |
| 73 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06825267 |
| 74 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06533713 |
| 75 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06320016 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05127750 |
| 77 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04725678 |
| 78 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.04540061 |
| 79 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04299334 |
| 80 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.03858390 |
| 81 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.03472523 |
| 82 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.03471781 |
| 83 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.01867140 |
| 84 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.01517234 |
| 85 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.01097038 |
| 86 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.00108719 |
| 87 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.99938598 |
| 88 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.99846628 |
| 89 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.99744667 |
| 90 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.99377600 |
| 91 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.99345823 |
| 92 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.99047426 |
| 93 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98803879 |
| 94 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.98276175 |
| 95 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97833743 |
| 96 | GATA1_22025678_ChIP-Seq_K562_Human | 0.97409177 |
| 97 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.97250538 |
| 98 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.95610845 |
| 99 | KDM2B_26808549_Chip-Seq_K562_Human | 0.94608442 |
| 100 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94171748 |
| 101 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.93805689 |
| 102 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.93344583 |
| 103 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93327991 |
| 104 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.93173428 |
| 105 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.91774438 |
| 106 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.91692560 |
| 107 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.91081293 |
| 108 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.90273352 |
| 109 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90090390 |
| 110 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.88190841 |
| 111 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.86839612 |
| 112 | * SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.84561402 |
| 113 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.83740848 |
| 114 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.83034683 |
| 115 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.82847158 |
| 116 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.82726768 |
| 117 | * SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.81571178 |
| 118 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.79816245 |
| 119 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.79614081 |
| 120 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.78829368 |
| 121 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.78602451 |
| 122 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.76393629 |
| 123 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.75687143 |
| 124 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.75346511 |
| 125 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.75247193 |
| 126 | GATA1_19941826_ChIP-Seq_K562_Human | 0.74205903 |
| 127 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.71863514 |
| 128 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.70390816 |
| 129 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.69973181 |
| 130 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.69791494 |
| 131 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.69565036 |
| 132 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.66780956 |
| 133 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.66206761 |
| 134 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.64424192 |
| 135 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.64098302 |
| 136 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.63743254 |
| 137 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.63299958 |
| 138 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.62958484 |
| 139 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.62872768 |
| 140 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.62299664 |
| 141 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.61904044 |
| 142 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.61635044 |
| 143 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.61457977 |
| 144 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.61288030 |
| 145 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.61147254 |
| 146 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.61067672 |
| 147 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.60590306 |
| 148 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.60555658 |
| 149 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.60390468 |
| 150 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.59411915 |
| 151 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.59179697 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.63151615 |
| 2 | MP0005360_urolithiasis | 6.95185288 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.48528551 |
| 4 | MP0005365_abnormal_bile_salt | 6.20061228 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.63336053 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.32652539 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.34392076 |
| 8 | MP0003252_abnormal_bile_duct | 3.33274263 |
| 9 | MP0009840_abnormal_foam_cell | 3.09915526 |
| 10 | MP0005083_abnormal_biliary_tract | 2.75486961 |
| 11 | MP0005332_abnormal_amino_acid | 2.67762788 |
| 12 | MP0009379_abnormal_foot_pigmentation | 2.54646372 |
| 13 | MP0003656_abnormal_erythrocyte_physiolo | 2.38057167 |
| 14 | MP0008438_abnormal_cutaneous_collagen | 2.35488222 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.34047002 |
| 16 | MP0004858_abnormal_nervous_system | 2.30846211 |
| 17 | MP0003195_calcinosis | 2.29116639 |
| 18 | MP0001666_abnormal_nutrient_absorption | 2.25474975 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.25211789 |
| 20 | MP0000609_abnormal_liver_physiology | 2.17567951 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 2.09286854 |
| 22 | MP0000343_altered_response_to | 2.02747851 |
| 23 | MP0005319_abnormal_enzyme/_coenzyme | 1.81058518 |
| 24 | MP0003183_abnormal_peptide_metabolism | 1.78219353 |
| 25 | MP0005257_abnormal_intraocular_pressure | 1.78000910 |
| 26 | MP0001542_abnormal_bone_strength | 1.76089477 |
| 27 | MP0003279_aneurysm | 1.74166233 |
| 28 | MP0001764_abnormal_homeostasis | 1.71468392 |
| 29 | MP0000681_abnormal_thyroid_gland | 1.66125565 |
| 30 | MP0000678_abnormal_parathyroid_gland | 1.64194027 |
| 31 | MP0003303_peritoneal_inflammation | 1.50042212 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.42505789 |
| 33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.41805922 |
| 34 | MP0003186_abnormal_redox_activity | 1.38542953 |
| 35 | MP0008057_abnormal_DNA_replication | 1.38126059 |
| 36 | MP0003868_abnormal_feces_composition | 1.36518171 |
| 37 | MP0005647_abnormal_sex_gland | 1.29285678 |
| 38 | MP0003705_abnormal_hypodermis_morpholog | 1.29195257 |
| 39 | MP0006054_spinal_hemorrhage | 1.27344622 |
| 40 | MP0002877_abnormal_melanocyte_morpholog | 1.26727889 |
| 41 | MP0000598_abnormal_liver_morphology | 1.23332624 |
| 42 | MP0004272_abnormal_basement_membrane | 1.20639695 |
| 43 | MP0009278_abnormal_bone_marrow | 1.20226604 |
| 44 | MP0008004_abnormal_stomach_pH | 1.18445573 |
| 45 | MP0000858_altered_metastatic_potential | 1.17912349 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.14216529 |
| 47 | MP0002148_abnormal_hypersensitivity_rea | 1.11680111 |
| 48 | MP0002653_abnormal_ependyma_morphology | 1.11307675 |
| 49 | MP0001849_ear_inflammation | 1.11107974 |
| 50 | MP0001881_abnormal_mammary_gland | 1.10918096 |
| 51 | MP0005165_increased_susceptibility_to | 1.10574293 |
| 52 | MP0000639_abnormal_adrenal_gland | 1.09772555 |
| 53 | MP0005670_abnormal_white_adipose | 1.06564645 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.06334966 |
| 55 | MP0004130_abnormal_muscle_cell | 1.03640417 |
| 56 | MP0002971_abnormal_brown_adipose | 1.03269612 |
| 57 | MP0005508_abnormal_skeleton_morphology | 1.02916406 |
| 58 | MP0005166_decreased_susceptibility_to | 1.01898054 |
| 59 | MP0005058_abnormal_lysosome_morphology | 1.01565686 |
| 60 | MP0003436_decreased_susceptibility_to | 1.01437413 |
| 61 | MP0005266_abnormal_metabolism | 1.01402900 |
| 62 | MP0005451_abnormal_body_composition | 1.01332696 |
| 63 | MP0009643_abnormal_urine_homeostasis | 1.01260187 |
| 64 | MP0001958_emphysema | 1.00642845 |
| 65 | MP0001663_abnormal_digestive_system | 1.00450717 |
| 66 | MP0005390_skeleton_phenotype | 1.00358983 |
| 67 | MP0002896_abnormal_bone_mineralization | 0.97854576 |
| 68 | MP0003879_abnormal_hair_cell | 0.97421826 |
| 69 | MP0005376_homeostasis/metabolism_phenot | 0.97172728 |
| 70 | MP0006036_abnormal_mitochondrial_physio | 0.96682848 |
| 71 | MP0000490_abnormal_crypts_of | 0.95870874 |
| 72 | MP0009697_abnormal_copulation | 0.95467172 |
| 73 | MP0005171_absent_coat_pigmentation | 0.94896691 |
| 74 | MP0003329_amyloid_beta_deposits | 0.94830986 |
| 75 | MP0002998_abnormal_bone_remodeling | 0.93980638 |
| 76 | MP0003453_abnormal_keratinocyte_physiol | 0.91883291 |
| 77 | MP0005501_abnormal_skin_physiology | 0.86808922 |
| 78 | MP0008260_abnormal_autophagy | 0.86632071 |
| 79 | MP0000579_abnormal_nail_morphology | 0.86503296 |
| 80 | MP0005023_abnormal_wound_healing | 0.85998211 |
| 81 | MP0004510_myositis | 0.85592864 |
| 82 | MP0003011_delayed_dark_adaptation | 0.84891212 |
| 83 | MP0002254_reproductive_system_inflammat | 0.83557905 |
| 84 | MP0009115_abnormal_fat_cell | 0.83358097 |
| 85 | MP0009053_abnormal_anal_canal | 0.80326506 |
| 86 | MP0005503_abnormal_tendon_morphology | 0.80198288 |
| 87 | MP0005381_digestive/alimentary_phenotyp | 0.79643864 |
| 88 | MP0005334_abnormal_fat_pad | 0.78986512 |
| 89 | MP0009763_increased_sensitivity_to | 0.78261458 |
| 90 | MP0000604_amyloidosis | 0.77853336 |
| 91 | MP0001756_abnormal_urination | 0.77685995 |
| 92 | MP0010030_abnormal_orbit_morphology | 0.76999327 |
| 93 | MP0005397_hematopoietic_system_phenotyp | 0.76355737 |
| 94 | MP0001545_abnormal_hematopoietic_system | 0.76355737 |
| 95 | MP0009764_decreased_sensitivity_to | 0.76274603 |
| 96 | MP0002796_impaired_skin_barrier | 0.75736908 |
| 97 | MP0009785_altered_susceptibility_to | 0.75159949 |
| 98 | MP0003724_increased_susceptibility_to | 0.74587871 |
| 99 | MP0002295_abnormal_pulmonary_circulatio | 0.74239831 |
| 100 | MP0009642_abnormal_blood_homeostasis | 0.73849361 |
| 101 | MP0000538_abnormal_urinary_bladder | 0.73691951 |
| 102 | MP0003448_altered_tumor_morphology | 0.73318866 |
| 103 | MP0004782_abnormal_surfactant_physiolog | 0.71667300 |
| 104 | MP0002009_preneoplasia | 0.71632562 |
| 105 | MP0002419_abnormal_innate_immunity | 0.71382364 |
| 106 | MP0009384_cardiac_valve_regurgitation | 0.70752516 |
| 107 | MP0008995_early_reproductive_senescence | 0.70576844 |
| 108 | MP0003718_maternal_effect | 0.70438272 |
| 109 | MP0003075_altered_response_to | 0.70370408 |
| 110 | MP0002249_abnormal_larynx_morphology | 0.69297138 |
| 111 | MP0005275_abnormal_skin_tensile | 0.69205847 |
| 112 | MP0002078_abnormal_glucose_homeostasis | 0.68077416 |
| 113 | MP0006082_CNS_inflammation | 0.68064116 |
| 114 | MP0010368_abnormal_lymphatic_system | 0.67692414 |
| 115 | MP0005595_abnormal_vascular_smooth | 0.67592943 |
| 116 | MP0009780_abnormal_chondrocyte_physiolo | 0.65614362 |
| 117 | MP0005636_abnormal_mineral_homeostasis | 0.65586632 |
| 118 | MP0008469_abnormal_protein_level | 0.65372670 |
| 119 | MP0003638_abnormal_response/metabolism_ | 0.64583531 |
| 120 | MP0003172_abnormal_lysosome_physiology | 0.63546126 |
| 121 | MP0002269_muscular_atrophy | 0.63415323 |
| 122 | MP0002970_abnormal_white_adipose | 0.63121743 |
| 123 | MP0002282_abnormal_trachea_morphology | 0.62451999 |
| 124 | MP0005395_other_phenotype | 0.62337079 |
| 125 | MP0005666_abnormal_adipose_tissue | 0.61332031 |
| 126 | MP0004233_abnormal_muscle_weight | 0.60509828 |
| 127 | MP0001661_extended_life_span | 0.60392806 |
| 128 | MP0005220_abnormal_exocrine_pancreas | 0.58697739 |
| 129 | MP0003690_abnormal_glial_cell | 0.58180855 |
| 130 | MP0003890_abnormal_embryonic-extraembry | 0.56671552 |
| 131 | MP0002060_abnormal_skin_morphology | 0.56010227 |
| 132 | MP0005464_abnormal_platelet_physiology | 0.54837397 |
| 133 | MP0005535_abnormal_body_temperature | 0.54312102 |
| 134 | MP0005075_abnormal_melanosome_morpholog | 0.53952682 |
| 135 | MP0008874_decreased_physiological_sensi | 0.53821435 |
| 136 | MP0005448_abnormal_energy_balance | 0.52463976 |
| 137 | MP0004185_abnormal_adipocyte_glucose | 0.51726891 |
| 138 | MP0009765_abnormal_xenobiotic_induced | 0.50981340 |
| 139 | MP0004147_increased_porphyrin_level | 0.48335130 |
| 140 | MP0008873_increased_physiological_sensi | 0.47951838 |
| 141 | MP0005248_abnormal_Harderian_gland | 0.45982793 |
| 142 | MP0001324_abnormal_eye_pigmentation | 0.45696245 |
| 143 | MP0000371_diluted_coat_color | 0.45173941 |
| 144 | MP0004264_abnormal_extraembryonic_tissu | 0.45059365 |
| 145 | MP0002876_abnormal_thyroid_physiology | 0.44475309 |
| 146 | MP0004133_heterotaxia | 0.44174560 |
| 147 | MP0002332_abnormal_exercise_endurance | 0.44162653 |
| 148 | MP0002168_other_aberrant_phenotype | 0.38892945 |
| 149 | MP0003953_abnormal_hormone_level | 0.38774639 |
| 150 | MP0001340_abnormal_eyelid_morphology | 0.38696645 |
| 151 | MP0008872_abnormal_physiological_respon | 0.37156585 |
| 152 | MP0002132_abnormal_respiratory_system | 0.36020652 |
| 153 | MP0005330_cardiomyopathy | 0.35317782 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.97148073 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.64175609 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.48330219 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 6.18806266 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.00372050 |
| 6 | Xanthomatosis (HP:0000991) | 5.64788664 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.55178543 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 5.16569624 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.16569624 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.16569624 |
| 11 | Hypochromic microcytic anemia (HP:0004840) | 5.13672581 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 4.92270863 |
| 13 | Complement deficiency (HP:0004431) | 4.82540103 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.52136500 |
| 15 | Hyperammonemia (HP:0001987) | 4.42667083 |
| 16 | Joint hemorrhage (HP:0005261) | 4.14669762 |
| 17 | Dysostosis multiplex (HP:0000943) | 4.11241363 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.10705784 |
| 19 | Vertebral compression fractures (HP:0002953) | 4.07987504 |
| 20 | Ketosis (HP:0001946) | 4.07448010 |
| 21 | Hyperglycinemia (HP:0002154) | 4.03443715 |
| 22 | Epidermoid cyst (HP:0200040) | 3.95257128 |
| 23 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.83941672 |
| 24 | Hyperglycinuria (HP:0003108) | 3.82548884 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.80402339 |
| 26 | Vacuolated lymphocytes (HP:0001922) | 3.80181407 |
| 27 | Abnormality of methionine metabolism (HP:0010901) | 3.80118514 |
| 28 | Hypoalphalipoproteinemia (HP:0003233) | 3.78491963 |
| 29 | Fat malabsorption (HP:0002630) | 3.73711834 |
| 30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.67819268 |
| 31 | Abnormality of glycine metabolism (HP:0010895) | 3.67819268 |
| 32 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.67313840 |
| 33 | Abnormality of complement system (HP:0005339) | 3.65355067 |
| 34 | Abnormality of the common coagulation pathway (HP:0010990) | 3.60999266 |
| 35 | Abnormality of proline metabolism (HP:0010907) | 3.54132013 |
| 36 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.47667199 |
| 37 | Hypoglycemic coma (HP:0001325) | 3.31045718 |
| 38 | Myocardial infarction (HP:0001658) | 3.30725310 |
| 39 | Turricephaly (HP:0000262) | 3.28640459 |
| 40 | Hyperbilirubinemia (HP:0002904) | 3.21909577 |
| 41 | Ketoacidosis (HP:0001993) | 3.20292138 |
| 42 | Petechiae (HP:0000967) | 3.19414564 |
| 43 | Hypercholesterolemia (HP:0003124) | 3.18681489 |
| 44 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.17410286 |
| 45 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.17410286 |
| 46 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.17410286 |
| 47 | Axonal loss (HP:0003447) | 3.15917919 |
| 48 | Ileus (HP:0002595) | 3.08505433 |
| 49 | Increased cerebral lipofuscin (HP:0011813) | 3.00938129 |
| 50 | Steatorrhea (HP:0002570) | 2.97095065 |
| 51 | Abnormality of the intrinsic pathway (HP:0010989) | 2.95683676 |
| 52 | Nausea (HP:0002018) | 2.92991691 |
| 53 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.89192000 |
| 54 | Prolonged neonatal jaundice (HP:0006579) | 2.88516761 |
| 55 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.87092280 |
| 56 | Delayed CNS myelination (HP:0002188) | 2.84459819 |
| 57 | Alopecia of scalp (HP:0002293) | 2.84090331 |
| 58 | Purpura (HP:0000979) | 2.84027786 |
| 59 | Protrusio acetabuli (HP:0003179) | 2.81581522 |
| 60 | Conjugated hyperbilirubinemia (HP:0002908) | 2.78249070 |
| 61 | Hepatocellular carcinoma (HP:0001402) | 2.72821567 |
| 62 | Polycythemia (HP:0001901) | 2.66687534 |
| 63 | Abnormality of nucleobase metabolism (HP:0010932) | 2.66220891 |
| 64 | Abnormality of serum amino acid levels (HP:0003112) | 2.65849635 |
| 65 | Loss of speech (HP:0002371) | 2.63542618 |
| 66 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.62250926 |
| 67 | Hyperparathyroidism (HP:0000843) | 2.59314498 |
| 68 | Poikilocytosis (HP:0004447) | 2.58996327 |
| 69 | Opisthotonus (HP:0002179) | 2.54653380 |
| 70 | Pustule (HP:0200039) | 2.53344682 |
| 71 | Acanthocytosis (HP:0001927) | 2.52919030 |
| 72 | Premature rupture of membranes (HP:0001788) | 2.52706428 |
| 73 | Cholelithiasis (HP:0001081) | 2.52008296 |
| 74 | Abnormal gallbladder morphology (HP:0012437) | 2.50870829 |
| 75 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.48922309 |
| 76 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.48873766 |
| 77 | Lethargy (HP:0001254) | 2.47851933 |
| 78 | Abnormal hemoglobin (HP:0011902) | 2.46986774 |
| 79 | Spastic diplegia (HP:0001264) | 2.46578754 |
| 80 | Malnutrition (HP:0004395) | 2.40365487 |
| 81 | Cerebral palsy (HP:0100021) | 2.39495740 |
| 82 | Spontaneous abortion (HP:0005268) | 2.39005857 |
| 83 | Systemic lupus erythematosus (HP:0002725) | 2.37304489 |
| 84 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.36753179 |
| 85 | Metabolic acidosis (HP:0001942) | 2.36042818 |
| 86 | Hypochromic anemia (HP:0001931) | 2.33656121 |
| 87 | Irritability (HP:0000737) | 2.32913781 |
| 88 | Skin nodule (HP:0200036) | 2.31760078 |
| 89 | Nuclear cataract (HP:0100018) | 2.30997237 |
| 90 | Cervical subluxation (HP:0003308) | 2.27322154 |
| 91 | Abnormality of purine metabolism (HP:0004352) | 2.25497737 |
| 92 | Nonimmune hydrops fetalis (HP:0001790) | 2.25344332 |
| 93 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.25204372 |
| 94 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.25204372 |
| 95 | Single umbilical artery (HP:0001195) | 2.25204372 |
| 96 | Lower limb hyperreflexia (HP:0002395) | 2.20896971 |
| 97 | J-shaped sella turcica (HP:0002680) | 2.20668232 |
| 98 | Abnormal gallbladder physiology (HP:0012438) | 2.18482156 |
| 99 | Cholecystitis (HP:0001082) | 2.18482156 |
| 100 | Increased serum ferritin (HP:0003281) | 2.16514732 |
| 101 | Menorrhagia (HP:0000132) | 2.15546004 |
| 102 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.15282389 |
| 103 | Dicarboxylic aciduria (HP:0003215) | 2.15282389 |
| 104 | Coronal craniosynostosis (HP:0004440) | 2.14694758 |
| 105 | Progressive neurologic deterioration (HP:0002344) | 2.08724045 |
| 106 | Vascular calcification (HP:0004934) | 2.07460957 |
| 107 | Acute hepatic failure (HP:0006554) | 2.06248232 |
| 108 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.05930633 |
| 109 | Nephritis (HP:0000123) | 2.05694141 |
| 110 | Reticulocytosis (HP:0001923) | 2.05642472 |
| 111 | Neonatal onset (HP:0003623) | 2.03417542 |
| 112 | Cerebral edema (HP:0002181) | 2.00317918 |
| 113 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.99838075 |
| 114 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.99838075 |
| 115 | Joint stiffness (HP:0001387) | 1.98504566 |
| 116 | Vomiting (HP:0002013) | 1.98129826 |
| 117 | Esophageal varix (HP:0002040) | 1.98121719 |
| 118 | Vaginal fistula (HP:0004320) | 1.97809405 |
| 119 | Mucopolysacchariduria (HP:0008155) | 1.97013930 |
| 120 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.97013930 |
| 121 | Hypoglycemic seizures (HP:0002173) | 1.96561701 |
| 122 | Abnormality of macrophages (HP:0004311) | 1.96286807 |
| 123 | Abnormality of iron homeostasis (HP:0011031) | 1.96227659 |
| 124 | Protuberant abdomen (HP:0001538) | 1.95035764 |
| 125 | Gout (HP:0001997) | 1.94988155 |
| 126 | Hypophosphatemia (HP:0002148) | 1.94777591 |
| 127 | Hemorrhage of the eye (HP:0011885) | 1.93530902 |
| 128 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.93382522 |
| 129 | Peritonitis (HP:0002586) | 1.92981233 |
| 130 | Rickets (HP:0002748) | 1.92701778 |
| 131 | Ulnar bowing (HP:0003031) | 1.92508489 |
| 132 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.92204750 |
| 133 | Abnormality of the gallbladder (HP:0005264) | 1.90865972 |
| 134 | Abnormality of the umbilical cord (HP:0010881) | 1.90745405 |
| 135 | Glomerulonephritis (HP:0000099) | 1.90336785 |
| 136 | Status epilepticus (HP:0002133) | 1.89468834 |
| 137 | Pathologic fracture (HP:0002756) | 1.88456388 |
| 138 | Amyloidosis (HP:0011034) | 1.87617876 |
| 139 | Increased mean platelet volume (HP:0011877) | 1.87262498 |
| 140 | Increased IgM level (HP:0003496) | 1.86454762 |
| 141 | Brushfield spots (HP:0001088) | 1.86092047 |
| 142 | Abdominal distention (HP:0003270) | 1.85039754 |
| 143 | Hepatosplenomegaly (HP:0001433) | 1.84462772 |
| 144 | Abnormality of the Achilles tendon (HP:0005109) | 1.83759650 |
| 145 | Hydroxyprolinuria (HP:0003080) | 1.83196301 |
| 146 | Thin bony cortex (HP:0002753) | 1.83066696 |
| 147 | Confusion (HP:0001289) | 1.78818196 |
| 148 | Cardiomegaly (HP:0001640) | 1.78550118 |
| 149 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.75871996 |
| 150 | Wide cranial sutures (HP:0010537) | 1.75452047 |
| 151 | Bone pain (HP:0002653) | 1.75093785 |
| 152 | Asymmetric septal hypertrophy (HP:0001670) | 1.74250856 |
| 153 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.73139023 |
| 154 | Achilles tendon contracture (HP:0001771) | 1.72971734 |
| 155 | Bulbar palsy (HP:0001283) | 1.72114596 |
| 156 | Multiple lipomas (HP:0001012) | 1.71429535 |
| 157 | Blue sclerae (HP:0000592) | 1.70916451 |
| 158 | Diaphragmatic weakness (HP:0009113) | 1.68502907 |
| 159 | Widely patent fontanelles and sutures (HP:0004492) | 1.66977414 |
| 160 | Thoracic kyphosis (HP:0002942) | 1.65234680 |
| 161 | Nephrolithiasis (HP:0000787) | 1.63659150 |
| 162 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.63482873 |
| 163 | Macrocytic anemia (HP:0001972) | 1.63345001 |
| 164 | Fragile skin (HP:0001030) | 1.62244990 |
| 165 | Metaphyseal irregularity (HP:0003025) | 1.60291036 |
| 166 | Genu recurvatum (HP:0002816) | 1.60150607 |
| 167 | Disinhibition (HP:0000734) | 1.59531945 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ICK | 5.20617037 |
| 2 | MAPK15 | 4.90240552 |
| 3 | NME2 | 4.76914190 |
| 4 | BCKDK | 4.03860870 |
| 5 | DDR2 | 4.00836333 |
| 6 | MAP3K6 | 3.84460033 |
| 7 | PINK1 | 3.44086913 |
| 8 | MAP3K11 | 3.31185357 |
| 9 | TESK1 | 3.22216893 |
| 10 | MYLK | 2.87288020 |
| 11 | IRAK3 | 2.76269130 |
| 12 | TESK2 | 2.72256569 |
| 13 | SIK1 | 2.67196374 |
| 14 | FGR | 2.36347883 |
| 15 | MATK | 2.30507598 |
| 16 | LIMK1 | 2.20355050 |
| 17 | DYRK1B | 2.18289647 |
| 18 | EPHB2 | 2.16683145 |
| 19 | TYRO3 | 2.16238697 |
| 20 | CSK | 2.15175055 |
| 21 | BMX | 2.09335292 |
| 22 | ERN1 | 2.03875377 |
| 23 | MAPK11 | 1.99506168 |
| 24 | DAPK1 | 1.97400275 |
| 25 | FGFR4 | 1.95034643 |
| 26 | VRK2 | 1.92668196 |
| 27 | ARAF | 1.89999973 |
| 28 | CDK6 | 1.76501832 |
| 29 | PDGFRA | 1.72760496 |
| 30 | MAP3K12 | 1.70216734 |
| 31 | TGFBR2 | 1.67054051 |
| 32 | PRKD2 | 1.66394067 |
| 33 | UHMK1 | 1.59814808 |
| 34 | PIM2 | 1.55673596 |
| 35 | PAK4 | 1.54438025 |
| 36 | ACVR1B | 1.54183294 |
| 37 | TRIB3 | 1.45324606 |
| 38 | YES1 | 1.37497348 |
| 39 | PRKG2 | 1.33056413 |
| 40 | TBK1 | 1.32118129 |
| 41 | GSK3A | 1.30462988 |
| 42 | AKT3 | 1.24552764 |
| 43 | TAOK1 | 1.23784190 |
| 44 | ERBB4 | 1.23274398 |
| 45 | ILK | 1.21168018 |
| 46 | MAP3K10 | 1.15747789 |
| 47 | PIM1 | 1.12462108 |
| 48 | GRK7 | 1.12221696 |
| 49 | FLT3 | 1.07600834 |
| 50 | RPS6KL1 | 1.04750756 |
| 51 | RPS6KC1 | 1.04750756 |
| 52 | TRPM7 | 1.04572720 |
| 53 | LATS2 | 1.03188534 |
| 54 | PRKAA2 | 1.01296887 |
| 55 | MAP3K1 | 0.97552709 |
| 56 | PRKAA1 | 0.97497324 |
| 57 | DAPK3 | 0.96997279 |
| 58 | BRAF | 0.95931026 |
| 59 | CDK7 | 0.94650608 |
| 60 | CDK19 | 0.93511126 |
| 61 | MUSK | 0.93231931 |
| 62 | MOS | 0.92754403 |
| 63 | RPS6KA6 | 0.92697337 |
| 64 | PIK3CA | 0.88612258 |
| 65 | TAOK3 | 0.87905505 |
| 66 | RPS6KA2 | 0.87298435 |
| 67 | MAP2K2 | 0.83156021 |
| 68 | TAOK2 | 0.83051166 |
| 69 | EIF2AK1 | 0.81428753 |
| 70 | JAK2 | 0.81107786 |
| 71 | CAMK2G | 0.78392134 |
| 72 | ABL2 | 0.76385911 |
| 73 | LATS1 | 0.74450835 |
| 74 | INSRR | 0.74018542 |
| 75 | IKBKB | 0.73345071 |
| 76 | MAPK4 | 0.72459916 |
| 77 | PHKG2 | 0.71863041 |
| 78 | PHKG1 | 0.71863041 |
| 79 | DMPK | 0.71480718 |
| 80 | PDPK1 | 0.71388720 |
| 81 | MTOR | 0.71375256 |
| 82 | CDC42BPA | 0.70724181 |
| 83 | LRRK2 | 0.70221295 |
| 84 | PBK | 0.69775352 |
| 85 | DAPK2 | 0.67732864 |
| 86 | PAK1 | 0.67240924 |
| 87 | PRKCZ | 0.66887676 |
| 88 | MST1R | 0.65819372 |
| 89 | PDK2 | 0.65361822 |
| 90 | STK16 | 0.64571544 |
| 91 | MET | 0.60485843 |
| 92 | PKN2 | 0.58402533 |
| 93 | MAPKAPK3 | 0.57450221 |
| 94 | MAP2K4 | 0.56668198 |
| 95 | RPS6KA1 | 0.56278397 |
| 96 | GRK5 | 0.55741054 |
| 97 | EGFR | 0.55688532 |
| 98 | PRKACG | 0.55576095 |
| 99 | CSNK1G1 | 0.55332475 |
| 100 | MAP3K8 | 0.55028840 |
| 101 | SMG1 | 0.54841073 |
| 102 | MAPKAPK2 | 0.51922808 |
| 103 | AKT2 | 0.49535665 |
| 104 | PTK2 | 0.48306601 |
| 105 | TYK2 | 0.47774412 |
| 106 | CAMK1D | 0.47036995 |
| 107 | SCYL2 | 0.45558398 |
| 108 | PIK3CG | 0.45506234 |
| 109 | ADRBK2 | 0.45170170 |
| 110 | CAMK2D | 0.44799859 |
| 111 | RIPK1 | 0.44544475 |
| 112 | IRAK2 | 0.43686713 |
| 113 | CSNK1G3 | 0.41625396 |
| 114 | LYN | 0.39112305 |
| 115 | CDK11A | 0.38691728 |
| 116 | KDR | 0.38480533 |
| 117 | MAP3K5 | 0.38440968 |
| 118 | DYRK3 | 0.38096460 |
| 119 | ERBB2 | 0.37713049 |
| 120 | CDK14 | 0.37299779 |
| 121 | MAPK3 | 0.37148137 |
| 122 | CAMK2B | 0.35730106 |
| 123 | GRK6 | 0.35688729 |
| 124 | IKBKE | 0.35022775 |
| 125 | CDK4 | 0.34685347 |
| 126 | PAK2 | 0.34245105 |
| 127 | STK38L | 0.33123738 |
| 128 | CSNK1A1L | 0.32522140 |
| 129 | EPHB1 | 0.32177479 |
| 130 | HIPK2 | 0.31777437 |
| 131 | CHUK | 0.30456687 |
| 132 | CSNK2A1 | 0.30017505 |
| 133 | KIT | 0.29469860 |
| 134 | CDK15 | 0.29389709 |
| 135 | RPS6KB1 | 0.28966423 |
| 136 | MAPK1 | 0.28567401 |
| 137 | PRPF4B | 0.28420780 |
| 138 | MAP2K3 | 0.28159294 |
| 139 | MARK3 | 0.27994286 |
| 140 | MAP3K3 | 0.27923008 |
| 141 | MAPK7 | 0.27563607 |
| 142 | MAP2K6 | 0.27166763 |
| 143 | CDK18 | 0.25766122 |
| 144 | INSR | 0.25623923 |
| 145 | STK3 | 0.25595605 |
| 146 | ABL1 | 0.23984693 |
| 147 | PRKD1 | 0.23850454 |
| 148 | RAF1 | 0.23193867 |
| 149 | EPHA2 | 0.23016537 |
| 150 | FGFR2 | 0.22954721 |
| 151 | RPS6KA3 | 0.20911687 |
| 152 | MAPK12 | 0.20861927 |
| 153 | PTK6 | 0.20808613 |
| 154 | CAMK2A | 0.20419094 |
| 155 | MAP3K7 | 0.18684211 |
| 156 | CHEK2 | 0.18240413 |
| 157 | PRKCD | 0.16339198 |
| 158 | PDGFRB | 0.15724307 |
| 159 | CSNK2A2 | 0.15040592 |
| 160 | SGK1 | 0.14571344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.31736757 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.38981242 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.22746215 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.22467017 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.14770073 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.99262105 |
| 7 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.58658905 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.55137168 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.53798060 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.53473119 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.45304504 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.39262474 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.31226876 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.30665105 |
| 15 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.30324384 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.19948701 |
| 17 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.08438446 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.95480779 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.94433889 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.92665847 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.92043299 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.91785531 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85591221 |
| 24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.79072053 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.77806527 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.76001982 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.73108188 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.72108222 |
| 29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.67191682 |
| 30 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.64226937 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.62704818 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.62429391 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.61947297 |
| 34 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.55986402 |
| 35 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.51884824 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.51178590 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.50042102 |
| 38 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.49244972 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.48871554 |
| 40 | Mineral absorption_Homo sapiens_hsa04978 | 1.48048252 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.45074333 |
| 42 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.42332344 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.42026445 |
| 44 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.39655887 |
| 45 | Sulfur relay system_Homo sapiens_hsa04122 | 1.37018006 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.34534667 |
| 47 | Bile secretion_Homo sapiens_hsa04976 | 1.32768995 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.31530054 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.29790073 |
| 50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.29654242 |
| 51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28767063 |
| 52 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.28620545 |
| 53 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.21455368 |
| 54 | ABC transporters_Homo sapiens_hsa02010 | 1.17288873 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.17145719 |
| 56 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.16403254 |
| 57 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.15161940 |
| 58 | Ribosome_Homo sapiens_hsa03010 | 1.13110369 |
| 59 | Carbon metabolism_Homo sapiens_hsa01200 | 1.09878394 |
| 60 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.09645084 |
| 61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.04614332 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.01377037 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 1.00576616 |
| 64 | Pertussis_Homo sapiens_hsa05133 | 0.96509910 |
| 65 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.96329338 |
| 66 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.94155181 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89486087 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.89309068 |
| 69 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.88676812 |
| 70 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82167758 |
| 71 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.81239870 |
| 72 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78615612 |
| 73 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.76779968 |
| 74 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73300694 |
| 75 | Parkinsons disease_Homo sapiens_hsa05012 | 0.72438006 |
| 76 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.65587468 |
| 77 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.65423223 |
| 78 | Malaria_Homo sapiens_hsa05144 | 0.59853156 |
| 79 | Asthma_Homo sapiens_hsa05310 | 0.58035231 |
| 80 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.55577332 |
| 81 | Phagosome_Homo sapiens_hsa04145 | 0.53253948 |
| 82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49193210 |
| 83 | Alzheimers disease_Homo sapiens_hsa05010 | 0.48008754 |
| 84 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47718104 |
| 85 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47567910 |
| 86 | Huntingtons disease_Homo sapiens_hsa05016 | 0.44282138 |
| 87 | Salmonella infection_Homo sapiens_hsa05132 | 0.43115635 |
| 88 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.41114040 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | 0.41007722 |
| 90 | Tuberculosis_Homo sapiens_hsa05152 | 0.39895366 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.36934999 |
| 92 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.34339220 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.33364465 |
| 94 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32271966 |
| 95 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.30546572 |
| 96 | Base excision repair_Homo sapiens_hsa03410 | 0.28585402 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27577802 |
| 98 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.27500950 |
| 99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.26503023 |
| 100 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.23937739 |
| 101 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.23387522 |
| 102 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.23174053 |
| 103 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.22031616 |
| 104 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.20507282 |
| 105 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.19064100 |
| 106 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.18916126 |
| 107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18387048 |
| 108 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.16431911 |
| 109 | Mismatch repair_Homo sapiens_hsa03430 | 0.16355295 |
| 110 | Leishmaniasis_Homo sapiens_hsa05140 | 0.16258110 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14170725 |
| 112 | Circadian rhythm_Homo sapiens_hsa04710 | 0.13126587 |
| 113 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.11825160 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.11669723 |
| 115 | Bladder cancer_Homo sapiens_hsa05219 | 0.09608121 |
| 116 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.07759318 |
| 117 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.06245964 |
| 118 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.03660637 |
| 119 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.03415165 |
| 120 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.01236448 |
| 121 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | -0.1720463 |
| 122 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1667115 |
| 123 | Adherens junction_Homo sapiens_hsa04520 | -0.1663617 |
| 124 | DNA replication_Homo sapiens_hsa03030 | -0.1634439 |
| 125 | Lysosome_Homo sapiens_hsa04142 | -0.1583077 |
| 126 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | -0.1471318 |
| 127 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1303719 |
| 128 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0986563 |
| 129 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0856951 |
| 130 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0752309 |
| 131 | Notch signaling pathway_Homo sapiens_hsa04330 | -0.0594150 |

